DISCORDANCE BETWEEN PSYCHIATRISTS AND THEIR PATIENTS ON DISEASE SEVERITY AND TREATMENT OUTCOMES IN SCHIZOPHRENIA
Author(s)
Keenan A1, Lin D2, Joshi K2, Shepherd J3, Bailey H3, Wright J3, Meakin S3, Kim E2
1Janssen Global Services, LLC, Titusville, NJ, USA, 2Janssen Scientific Affairs, LLC, Titusville, NJ, USA, 3Adelphi Real World, Bollington, CHE, UK
OBJECTIVES: To assess discordance between psychiatrists and their patients with Schizophrenia in relation to disease severity and treatment outcomes. METHODS: A cross-sectional survey of psychiatrists and their patients with schizophrenia was conducted across the US, France, Spain, Japan and China between July and December 2019. Participating psychiatrists completed a patient record form (PRF) for their next 10 consulting adult patients with schizophrenia, with the same patients voluntarily completing a patient self-completion form (PSC). Both PRF and PSC surveyed on patients’ clinical characteristics, severity of illness and treatment outcomes. Kappa analysis was used to calculate agreement between psychiatrists and patients. RESULTS: A total of 456 psychiatrists provided data on 4189 patients, of which 2275 completed a PSC. Results were derived from matched PRF and PSC pairs. Discordance was observed between psychiatrists and their patients with Schizophrenia on patient’s severity of illness (kappa = 0.1744) and level of improvement on treatment (kappa = 0.2035) using Clinical Global Impression (CGI) scale. Compared to patients, psychiatrists tended to underrate patients’ severity of illness (16.6% of patients considered markedly/severely/extremely ill by psychiatrists, compared to 30.3% by patients themselves) and overrate the patients’ level of improvement on treatment, (72.0% of patients considered much/very improved by psychiatrists, compared to 46.9% by patients themselves). Where patients were not always compliant with schizophrenia treatment, psychiatrists tended to underestimate “taking medication is inconvenient” (6% psychiatrist reported vs 22% patient reported; kappa = 0.0909) and “do not see improvement on medication” (20% psychiatrist reported vs 49% patient reported; kappa = 0.0033) as key reasons for non-compliance. CONCLUSIONS: A disconnect was observed between psychiatrists and their patients with Schizophrenia on their respective perception of severity of illness, level of improvement and reasons for non-compliance with treatment, which could lead to sub-optimal treatment. Future research should investigate factors associated with such discordance.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Acceptance Code
PB3
Topic
Clinical Outcomes, Health Service Delivery & Process of Care, Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance, Clinician Reported Outcomes, Disease Management, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Mental Health